PD, PK, and Safety of ALTO-203 in Patients With MDD

Clinical trial NCT06391593 · COMPLETED

Trial details

NCT number: NCT06391593
Sponsor: Alto Neuroscience
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Major Depressive Disorder Anhedonia

Start date: 2024-03-25
Primary completion: 2025-04-14
Enrollment: 69

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.